These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16985228)

  • 1. Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
    Suk Danik J; Rifai N; Buring JE; Ridker PM
    JAMA; 2006 Sep; 296(11):1363-70. PubMed ID: 16985228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.
    Ridker PM; Rifai N; Cook NR; Bradwin G; Buring JE
    JAMA; 2005 Jul; 294(3):326-33. PubMed ID: 16030277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.
    Mora S; Buring JE; Ridker PM; Cui Y
    Ann Intern Med; 2011 Dec; 155(11):742-50. PubMed ID: 22147713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.
    Bansal S; Buring JE; Rifai N; Mora S; Sacks FM; Ridker PM
    JAMA; 2007 Jul; 298(3):309-16. PubMed ID: 17635891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
    Ridker PM; Rifai N; Rose L; Buring JE; Cook NR
    N Engl J Med; 2002 Nov; 347(20):1557-65. PubMed ID: 12432042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women.
    Mora S; Lee IM; Buring JE; Ridker PM
    JAMA; 2006 Mar; 295(12):1412-9. PubMed ID: 16551713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials.
    Willeit P; Ridker PM; Nestel PJ; Simes J; Tonkin AM; Pedersen TR; Schwartz GG; Olsson AG; Colhoun HM; Kronenberg F; Drechsler C; Wanner C; Mora S; Lesogor A; Tsimikas S
    Lancet; 2018 Oct; 392(10155):1311-1320. PubMed ID: 30293769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events.
    Suk Danik J; Rifai N; Buring JE; Ridker PM
    J Am Coll Cardiol; 2008 Jul; 52(2):124-31. PubMed ID: 18598891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol- or Apolipoprotein B-Related Risk of Coronary Heart Disease.
    Arnold N; Blaum C; Goßling A; Brunner FJ; Bay B; Zeller T; Ferrario MM; Brambilla P; Cesana G; Leoni V; Palmieri L; Donfrancesco C; Ojeda F; Linneberg A; Söderberg S; Iacoviello L; Gianfagna F; Costanzo S; Sans S; Veronesi G; Thorand B; Peters A; Tunstall-Pedoe H; Kee F; Salomaa V; Schnabel RB; Kuulasmaa K; Blankenberg S; Waldeyer C; Koenig W;
    J Am Coll Cardiol; 2024 Jul; 84(2):165-177. PubMed ID: 38960510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a).
    Maher VM; Brown BG; Marcovina SM; Hillger LA; Zhao XQ; Albers JJ
    JAMA; 1995 Dec; 274(22):1771-4. PubMed ID: 7500507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization.
    Roeseler E; Julius U; Heigl F; Spitthoever R; Heutling D; Breitenberger P; Leebmann J; Lehmacher W; Kamstrup PR; Nordestgaard BG; Maerz W; Noureen A; Schmidt K; Kronenberg F; Heibges A; Klingel R;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2019-27. PubMed ID: 27417585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein (a), lipids, aspirin, and risk of myocardial infarction in the Physician's Health Study.
    Ariyo A; Hennekens CH; Stampfer MJ; Ridker PM
    J Cardiovasc Risk; 1998 Aug; 5(4):273-8. PubMed ID: 9919476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
    J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of lipoprotein indices for residual risk of acute myocardial infarction and sudden death in men with low-density lipoprotein cholesterol levels <120 mg/dl.
    Tanaka F; Makita S; Onoda T; Tanno K; Ohsawa M; Itai K; Sakata K; Omama S; Yoshida Y; Ogasawara K; Ogawa A; Ishibashi Y; Kuribayashi T; Okayama A; Nakamura M;
    Am J Cardiol; 2013 Oct; 112(8):1063-8. PubMed ID: 23831165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study.
    Nomikos T; Panagiotakos D; Georgousopoulou E; Metaxa V; Chrysohoou C; Skoumas I; Antonopoulou S; Tousoulis D; Stefanadis C; Pitsavos C;
    Lipids Health Dis; 2015 Sep; 14():108. PubMed ID: 26370413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.